Trazodone for Sleep: Side Effects, Dosage, and Long-Term Reality in 2026

Trazodone for Sleep: Side Effects, Dosage, and the Long-Term Reality

Short answer: trazodone can cause drowsiness and may help some people sleep in the short term, but it is not FDA-approved as an insomnia medication. If you take it regularly for sleep, ask your clinician about side effects, next-day impairment, and whether CBT-I skills should be part of the plan.

Trazodone comes up constantly in sleep conversations because it is commonly prescribed off-label. Originally approved as an antidepressant, its sedating side effect is why many clinicians consider it for sleep. It is also not a controlled substance, which can make it feel simpler than some other sleep medications.

The tradeoff is that sedation can come with morning grogginess, dizziness, and a plan that still does not address the sleep patterns that keep chronic insomnia going.

What Trazodone Actually Does to Your Brain

Trazodone is a SARI — Serotonin Antagonist and Reuptake Inhibitor. At the doses used for depression (150-400mg for outpatients, with higher doses reserved for inpatient settings), it meaningfully boosts serotonin. But the doses commonly prescribed for sleep in practice are far lower — often cited as 25-100mg. The drug has a completely different mechanism at that lower range.

At these low doses, trazodone primarily blocks 5-HT2A (serotonin), H1 (histamine), and alpha-1 adrenergic receptors. Essentially, it turns down your brain's wakefulness drive. That heavy, physical drowsiness hitting you 30-60 minutes after the pill is not natural sleep arriving. Instead, it is a chemical suppression of your arousal system.

This distinction matters for anyone trying to improve insomnia symptoms. Trazodone may lower arousal, but it does not by itself retrain the bedtime habits, worry loops, or irregular schedules that can keep insomnia active.

The Research Is Thinner Than You'd Expect

For all its popularity, the clinical data supporting trazodone for primary insomnia is surprisingly weak. Most foundational studies looked at patients who had depression and insomnia. If your insomnia is not caused by depression — and for a significant portion of the population, it isn't — the clinical benefits shrink considerably.

When the American Academy of Sleep Medicine built its pharmacologic guideline (Sateia et al., 2017, DOI: 10.5664/jcsm.6470), only a single trial of trazodone 50 mg met its inclusion criteria. In that trial, patients fell asleep about 10 minutes faster than on placebo and slept about 22 minutes longer — both changes below the guideline's own thresholds for clinical significance. On that evidence, the guideline explicitly suggests that clinicians not use trazodone for sleep-onset or sleep-maintenance insomnia (a weak recommendation, reflecting the thin data). The guideline panel also noted that trazodone's popularity rests largely on physicians' perception of it as a safer sleep aid rather than on efficacy data.

Saving roughly ten minutes of wakefulness in exchange for a drug hangover that stretches into the morning is a tradeoff many eventually regret.

The "Trazodone Hangover" and Common Side Effects

Nobody stops trazodone because it works too well. They stop because of what happens the next morning. The half-life of trazodone is 5-9 hours. If you take it at midnight, the active drug is literally still circulating in your bloodstream when your 7 AM alarm goes off.

• Morning Grogginess: Lingering brain fog where you feel unplugged from your own body is the most common complaint.
• Dry Mouth and Dizziness: Trazodone's alpha-1 adrenergic blockade can cause orthostatic hypotension — standing up too fast and feeling dizzy — which is dose-dependent and more common in older adults, where it presents a significant fall risk. Dry mouth is also reported.
• Priapism: A rare but serious side effect involving prolonged, painful erections requiring emergency medical attention. It is critical to be aware of this risk, though many prescribers fail to mention it.
• REM Sleep Alteration: While less disruptive to sleep architecture than benzodiazepines, any chemical intervention reshapes the natural cycle.

The Warnings the Label Actually Carries

Trazodone is an antidepressant, and its FDA label opens with the antidepressant class boxed warning: suicidal thoughts and behaviors, with the risk concentrated in children, adolescents, and young adults — a group that overlaps heavily with insomnia sufferers who also live with depression or anxiety. The label's serious-warning list continues with serotonin syndrome (especially when combined with other serotonergic drugs, including some antidepressants, triptans, and tramadol), cardiac arrhythmias including QT prolongation, increased bleeding risk, low sodium, and activation of mania. None of these is common, but every one of them belongs in the conversation with your prescriber — particularly if trazodone was framed to you as "just a sleep aid."

Pros and Cons of Trazodone for Sleep

To provide a balanced view, here is a breakdown of what trazodone offers versus what it costs you in the long run:

Pros:

• Not a DEA-controlled substance (no addiction potential in the traditional sense).
• Sometimes used short-term for acute, stress-related sleeplessness while the underlying stressor resolves.
• Inexpensive and, in the US, widely covered by health insurance.

Cons:

• Morning hangover effect due to its 5-9 hour half-life.
• Orthostatic hypotension and dizziness on waking, especially in older adults — in nursing-home residents, low-dose trazodone was no safer than benzodiazepines for fall-related injuries (Bronskill et al., 2018).
• Fails to address the root psychological and behavioral causes of chronic insomnia.
• The label lists withdrawal symptoms on stopping — anxiety, agitation, and sleep problems — so discontinuation should be planned with the prescriber.
• Some people report the sedative effect fading over time.

Why CBT-I keeps coming up in insomnia guidelines

The American College of Physicians recommends CBT-I as the initial treatment for chronic insomnia, and the AASM's own pharmacologic guideline — as noted above — suggests against using trazodone for insomnia at all, while emphasizing behavioral treatment before or alongside medication decisions. This does not mean trazodone is never appropriate in an individual clinical picture. It means medication should not be the whole plan if insomnia is chronic.

If trazodone is a way to reduce arousal, CBT-I is the process of changing the patterns that tell your brain the bed is a place for wakefulness. Sleep restriction, stimulus control, and cognitive restructuring can help you practice a more consistent sleep rhythm while your clinician manages medication decisions.

Your brain does not build tolerance to behavioral techniques in the same way it may adapt to sedating medications. That is why CBT-I skills are worth discussing when trazodone helps only partially, creates morning impairment, or becomes something you feel unable to sleep without. The same logic applies if you tried supplements first: if melatonin stopped working and trazodone is the next suggestion, the sleep patterns underneath still deserve attention. If your clinician raises low-dose doxepin as another option, our evidence-first guide covers its benefits, limits, and risks.

How Zomni Fits In

The historical barrier to CBT-I was access. Finding a certified sleep psychologist, waiting months for an appointment, and paying out of pocket is not feasible for many people. That bottleneck is why Zomni was created — making structured CBT-I-informed guidance easier to access through your phone.

If you are currently taking trazodone, do not change your dose without your prescribing clinician. Zomni can sit alongside that care as CBT-I-informed wellness support: sleep windows, stimulus control, cognitive restructuring, and weekly reflection based on your sleep data. The goal is not to shame anyone for using medication, but to add skills that make the overall sleep plan more resilient.

Frequently Asked Questions (FAQ)

Is trazodone addictive? Physiologically, it is not a controlled substance like Xanax or Valium, meaning it does not cause chemical addiction. However, psychological dependence is very real. Your brain begins to require the "ritual" of the pill to grant itself permission to sleep.

When should I take trazodone for sleep? In practice it is usually taken 30-60 minutes before your planned bedtime; follow your prescriber's instructions. The FDA label advises taking trazodone shortly after a meal or light snack, which can also mitigate the stomach upset that some patients experience.

Can I drink alcohol while taking trazodone? No. The label warns that trazodone may enhance the effects of alcohol and other central nervous system depressants — the combination can markedly worsen drowsiness, dizziness, and loss of motor coordination. Skip alcohol while taking it.

Does trazodone lose its effectiveness over time? Some people report that the sedative effect becomes less helpful over time. If that happens, ask your clinician whether the next step should include CBT-I, sleep scheduling, anxiety support, or a medication review rather than simply increasing the dose.

The Honest Bottom Line

Trazodone has a place in some clinical pictures — short-term crisis management, insomnia intertwined with depression, or bridging the gap while you build better sleep skills — even though the guideline evidence behind it is thin.

But as a long-term strategy, relying for years on a nightly sedative that leaves you groggy may mean the underlying insomnia patterns are still untouched. A safer conversation is not "pill or no pill" — it is whether medication, CBT-I skills, and clinician follow-up are working together.

---

Medical Disclaimer: This article is provided for informational and educational purposes only and does not constitute medical advice. Zomni is a wellness application and is not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication taper. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.

References

• Furukawa, Y., et al. (2024). Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-analysis. JAMA Psychiatry. DOI: 10.1001/jamapsychiatry.2023.5060
• Sateia, M. J., et al. (2017). Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. DOI: 10.5664/jcsm.6470
• Qaseem, A., et al. (2016). Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. DOI: 10.7326/M15-2175
• Bronskill, S. E., et al. (2018). Low-Dose Trazodone, Benzodiazepines, and Fall-Related Injuries in Nursing Homes: A Matched-Cohort Study. Journal of the American Geriatrics Society. DOI: 10.1111/jgs.15519